ESTABLISHING A CORE OUTCOME MEASURE FOR LIFE PARTICIPATION: A STANDARDISED OUTCOMES IN NEPHROLOGY – KIDNEY TRANSPLANTATION (SONG-TX) CONSENSUS WORKSHOP REPORT

A JU1,2, M JOSEPHSON3, S JOWSEY-GREGOIRE4, J TAN5, Q TAYLOR6, K FOWLER7, F DOBBELS8, F  CASKEY9, V JHA10, J LOCKE11, G KNOLL12, C AHN13, C HANSON1,2, K  MANERA1,2, B SAUTENET14, J CRAIG1,2, A TONG1,2
1The University Of Sydney, Sydney, Australia, 2Centre for Kidney Research, Westmead, Australia , 3University of Chicago Medicine, Chicago, United States, 4Northwestern University , Evanston, United States , 5Mayo Clinic, Rochester, United States , 6Stanford  University School of Medicine, Stanford, United States , 7Patient Family Partnership Council, Kidney Health Initiative , Chicago, United States , 8KU Leuven , Leuven, Belgium, 9University of Bristol, Bristol, United Kingdom, 10The George Institute for Global Health, Oxford, United Kingdom, 11University of Alabama, Birmingham, United States , 12The Ottawa Hospital and University of Ottawa, Ottawa, Canada , 13Seoul National University Hospital, Seoul, South Korea , 14University Francois Rabelais , Tours, France

Background: Life participation is a critically important outcome for kidney transplant recipients but it is inconsistently and infrequently measured in trials. We convened a consensus workshop on establishing a core outcome measure for life participation for use in all trials in kidney transplantation.
Methods: Twenty-five (43%) kidney transplant recipients/caregivers and 33 (57%) health professionals from eight countries participated. Transcripts were analyzed thematically.
Results: Four themes were identified. Returning to normality illustrated the patients’ desires to fulfil their given role and re-establish a normal lifestyle. Recognizing the diverse meaning of ‘life’ explicitly acknowledged life participation as a subjective outcome that may refer to different activities for different patients. Capturing fluctuations in issues post-transplant recognized the long-term impact of transplantation and emphasized the need to consider time since receiving the transplant. Having a scientifically rigorous, feasible and meaningful measure would facilitate the consistent and frequent assessment of life participation in trials.
Conclusions: A simple and inexpensive core outcome measure for life participation will allow this important outcome to be consistently and meaningfully assessed in trials in kidney transplantation to inform decision-making and care of patients


Biography:
PhD student working on patient-reported outcome measures for fatigue in haemodialysis and life participation in kidney transplantation.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd